Sinopharm Group Co (X2S1) Income Statement
1 Followers
Sinopharm Group Co Income Statement
Last quarter (Q2 2026), Sinopharm Group Co's total revenue was ¥279.68B, a decrease of 5.11% from the same quarter last year. In Q2, Sinopharm Group Co's net income was ¥3.37B. See Sinopharm Group Co’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 559.50B | ¥ 584.51B | ¥ 596.57B | ¥ 552.15B | ¥ 521.05B | |
| ¥ 40.09B | ¥ 44.26B | ¥ 48.51B | ¥ 47.43B | ¥ 44.05B | |
| ¥ 23.88B | ¥ 28.07B | ¥ 28.30B | ¥ 26.83B | ¥ 24.34B | |
| Depreciation and Amortization | ¥ 4.29B | ¥ 4.73B | ¥ 4.43B | ¥ 4.17B | ¥ 3.92B |
| ¥ 20.50B | ¥ 22.55B | ¥ 26.90B | ¥ 26.25B | ¥ 24.68B | |
| ¥ 16.21B | ¥ 16.19B | ¥ 20.21B | ¥ 20.60B | ¥ 19.71B | |
| ¥ -1.82B | ¥ -2.19B | ¥ -697.06M | ¥ -2.04B | ¥ -2.71B | |
| ¥ 14.40B | ¥ 14.00B | ¥ 19.51B | ¥ 18.56B | ¥ 17.00B | |
| ¥ 6.96B | ¥ 7.05B | ¥ 9.05B | ¥ 8.53B | ¥ 7.76B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 11.10 | ¥ 11.30 | ¥ 14.50 | ¥ 13.65 | ¥ 12.45 |
| Diluted EPS | ¥ 11.10 | ¥ 11.30 | ¥ 14.50 | ¥ 13.65 | ¥ 12.45 |
| Weighted Average Shares Outstanding | 624.11M | 624.11M | 624.13M | 624.13M | 622.23M |
| Weighted Average Shares Outstanding (Diluted) | 624.11M | 624.11M | 624.13M | 624.13M | 622.23M |
Currency in CNY
